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Thymidylate synthase was one of the most studied enzymes due
to its critical role in molecular pathogenesis of cancer. Neverthe-
less, many atomistic details of its chemical mechanism remain
unknown or debated, thereby imposing limits on design of novel
mechanism-based anticancer therapeutics. Here, we report un-
precedented isolation and characterization of a previously pro-
posed intact noncovalent bisubstrate intermediate formed in the
reaction catalyzed by thymidylate synthase. Free-energy surfaces
of the bisubstrate intermediates interconversions computed with
quantum mechanics/molecular mechanics (QM/MM) methods and
experimental assessment of the corresponding kinetics indicate
that the species is the most abundant productive intermediate
along the reaction coordinate, whereas accumulation of the co-
valent bisubstrate species largely occurs in a parallel nonproduc-
tive pathway. Our findings not only substantiate relevance of the
previously proposed noncovalent intermediate but also support
potential implications of the overstabilized covalent intermediate
in drug design targeting DNA biosynthesis.
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Thymidylate synthase (TSase) was one of the first known an-ticancer drug targets due to its fundamental role in DNA
biosynthesis. Currently, most successful and widely used anti-
cancer treatments include agents specifically targeting TSase as
mechanism-based inhibitors (e.g., fluoropyrimidines, such as
capecitabine and tegafur). Other chemotherapeutic drugs mimic
the folate substrate of this enzyme, but no drug has combined
both moieties (1). Despite many therapeutic advantages, current
drugs are highly toxic and lead to resistance in tumor cells.
Demand for novel selective classes of TSase inhibitors fuels
reexamination of its mechanistic features to establish new
molecular targets.
TSase catalyzes reductive methylation of dUMP, where cosub-
strate N5N10-methylenetetrahydrofolate (CH2H4F) consecutively
donates a methylene and a hydride to form thymidylate (dTMP).
The mechanism of this transformation was proposed over 20 y
ago (2). While main features of this mechanism are commonly
recognized, certain details are open to debate. All previous
studies agree that the reaction is initiated on Michael addition of
the active site thiolate (Cys146) to the C6 position of dUMP and
formation of covalent ternary complex Int (Scheme 1, step 1)
[note that there is a debate on whether this step occurs through a
stepwise or concerted mechanism (2–7)].
However, two alternative pathways were proposed for the
subsequent proton abstraction step 2. Traditional mechanism
A features generation of the covalent enolate (or enol) inter-
mediate Int-A. Indirect support for existence of Int-A is pro-
vided by model studies of the nonenzymatic proton exchange
or dehalogenation at C5 of dUMP in the presence of thiols
(2). In contrast, recent quantum mechanics/molecular mechanics
(QM/MM) calculations predicted a much lower-energy pathway
B where the proton abstraction would occur concertedly with
C6-S bond cleavage, leading to the noncovalent intermediate
Int-B (6, 8). Both pathways predict conversion of Int-A or Int-B
to the covalent exocyclic methylene intermediate (steps 3A and
3B), which undergoes concerted reduction and C-S bond cleav-
age (step 4) to result in a final product dTMP (6, 9).
As a matter of fact, despite multiple intermediates having
been proposed along the reaction pathway of TSase, none of
them have ever been unambiguously structurally characterized.
Several studies reported detection of the intermediate covalently
bound to the active site cysteine of Lactobacillus casei and
Cryptosporidium hominis TSases, presumably representing Int or
Int-A (10–12). However, the only structural evidence involved
presence of radioactive labels originating from both of the sub-
strates (dUMP and CH2H4F) in the detected covalent adducts.
Studies by Anderson and coworkers (12–14) on C. hominis TSase
indicated isolation of a noncovalent intermediate on rapid
quenching with potassium hydroxide (but not on acid quench-
ing). However, no attempt was made to characterize the struc-
ture of the detected species, and it was proposed to represent
the iminium ion form of CH2H4F. In the work of Schultz and
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coworkers (4), the existence of the covalent exocyclic methylene
intermediate was indirectly supported on its trapping with
β-mercaptoethanol in TSase mutants. However, no report de-
scribed isolation and characterization of an intact intermediate
of TSase.
In a critical test of previous QM/MM predictions (6, 8), we
recently showed that chemically synthesized Int-B is indeed a
chemically and kinetically competent intermediate of the re-
action (15). Interestingly, inspection of the kinetics of Int-B
turnover by TSase suggested that its accumulation during the
natural course of the reaction would be sufficient for its de-
tection in a rapid quench experiment. These findings encouraged
us to attempt detection of Int-B transiently generated by TSase.
In this work, using a rapid chemical quench technique, we
showed formation of Int-B from the substrates dUMP and
CH2H4F in the presence of Escherichia coli thymidylate synthase
(EcTSase) and characterized its kinetics. Furthermore, we uti-
lized kinetic modeling along with QM/MM calculations to shed
light on the mechanism of the bisubstrate intermediates in-
terconversion in the active site of TSase. Our studies support
that noncovalent bisubstrate intermediates dominate in the cat-
alytic mechanism of TSase, whereas covalent bisubstrate species
are formed in a parallel nonproductive pathway.
Results and Discussion
Noncovalent Intermediate of TSase Is Formed During the Natural
Course of the Reaction. We performed a rapid chemical quench
of the EcTSase-catalyzed reaction containing [2-14C]dUMP and
[6-3H]CH2H4F and found both of the labels not only in dTMP
but also, in another species (Fig. 1B) independent of the nature
of the quencher (acid or base). Note that the peak observed with
UV detection at 16.6 min in Fig. 1A corresponds to [6-3H]H4F,
which is in equilibrium with [6-3H]CH2H4F (15). Therefore,
3H
signal at 18–20 min in Fig. 1B results from the overlap of the
signal corresponding to [6-3H]H4F and the double-labeled spe-
cies. Due to potential ambiguity of double-labeling experiment
caused by the interference of 3H signals of the folate derivatives
generated nonenzymatically from [6-3H]CH2H4F, we performed
additional experiments to gain certainty in the structure of the
detected intermediate. A peak arising from double-labeled spe-
cies was also observed with UV detection at 18.2 min (Fig. 1A).
Using the standard synthetic Int-B, we showed that retention
time, UV spectrum (Fig. 1A, Inset), and mass [high-resolution
mass spectrometrym/z (electrospray ionization) [M-H+]: observed
764.2050, standard 764.2047, calculated 764.2041] of the unknown
species are in excellent agreement with those of Int-B.
Kinetics of Noncovalent and Covalent Intermediate(s) Formation in
the TSase-Catalyzed Reaction Implies Parallel Reaction Pathways. To
gain additional support for kinetic competence of the detected
intermediate, we followed the time course of its transient for-
mation as well as dUMP consumption and dTMP generation
(Fig. 2, blue, pink, and green dots, respectively) on turnover
of [2-14C]dUMP in the presence of unlabeled CH2H4F and rapid
quenching of the reaction mixture with NaOH (0.33 M final;
base quench). Under these conditions, maximum accumulation
of intermediate reached ca. 34% of the total radioactivity, and
no radioactivity was associated with protein, suggesting that co-
valently bound intermediates either are not accumulated to a
detectable extent or are artificially released from the active site
under basic conditions. In contrast, when HCl (0.33 M final; acid
quench) was used as a quencher, despite that noncovalent in-
termediate was observed in the solution, a significant amount of
either covalently bound or coprecipitated 14C label was found in
the protein pellet, even for the reactions quenched after com-
pletion. Note that nucleotides are known to combine covalently
with TSase even in the absence of any folates, and these co-
valent complexes are stable under acid quench conditions (10).
Scheme 1. (A) Traditional and (B) proposed mechanisms of TSase-catalyzed
reaction.
Fig. 1. (A) Chromatogram at 260 nm of the EcTSase-catalyzed reaction
mixture quenched after 100 ms with hydrochloric acid (solid black) super-
imposed with the same reaction mixture coinjected with standard synthetic
Int-B (dotted red). (Inset) The UV spectrum of the peak at 18.2 min (solid
black) superimposed with the UV spectrum of standard Int-B (dotted red).
Reaction conditions: 50 μM EcTSase (dimer), 100 μM dUMP, 100 μM CH2H4F,
100 mM Tris·HCl, pH 7.5, 25 mM DTT, and 7 mM HCHO. (B) HPLC radiogram
of the EcTSase-catalyzed reaction mixture quenched after 100 ms with
hydrochloric acid. Reaction conditions: 50 μM EcTSase (dimer), 100 μM [2-14C]
dUMP, 200 μM [6-3H]CH2H4F, 100 mM Tris·HCl, pH 7.5, 25 mM DTT, and 7 mM
HCHO. Note the presence of both 14C and 3H labels in the peak corresponding
to Int-B (retention time: 18–20 min). DPM, disintegrations per minute.
10312 | www.pnas.org/cgi/doi/10.1073/pnas.1811059115 Kholodar et al.
Therefore, accurate measurement and interpretation of the ki-
netics of the noncovalent reaction components recovered under
conditions of the acid quench are compromised when radioactive
label is in the nucleotide. However, using radiolabeled CH2H4F
would allow for avoiding complexity associated with covalent
retention of nucleotides. However, inevitable equilibrium be-
tween CH2H4F and H4F and the unstable nature of the folates
lacking substitution at the position N5 preclude quantitative as-
sessment of the noncovalent reaction components, as it is also
discussed in the previous section. Since the focus of this study
was to investigate mechanistic details of formation and in-
terconversion of the bisubstrate intermediates of the reaction, we
chose to use base quench conditions and [2-14C]dUMP for ac-
curate examination of the kinetics of the 14C-labeled substrates,
products, and bisubstrate intermediates (covalent and non-
covalent). All of these species are quantitatively released from
TSase and are stable in the base. Furthermore, we exploited the
ability of the acid quench to preserve covalent interactions
between TSase and its intermediates to quantify the contribu-
tion of covalent bisubstrate intermediates under the base quench
conditions.
To avoid ambiguity of the signal originating from multiple
covalent enzyme complexes derived from radiolabeled nucleo-
tide as discussed above (10), we examined the time course of
covalently bound radiolabel originating from the folate. Using
[3ʹ,5ʹ,7,9-3H]CH2H4F and unlabeled dUMP, we followed accu-
mulation of the radioactivity covalently bound to protein on
rapid quenching of the reaction mixture with HCl (0.33 M final)
(Fig. 2, red dots). Any noncovalently bound ligands were re-
moved on denaturation of the protein with 2% SDS at pH 7.5
and spin filtration through a 10-kDa cutoff membrane. Although
the exact structure of the covalently bound adduct had not been
determined in this work, folate can only be covalently bound to
the TSase active site if it is a part of ternary covalent complex Int,
Int-A, and/or their corresponding protonated forms. As follows
from Fig. 2, covalently bound intermediate(s) accounts only for a
fraction of the total pool of Int-B detected on quenching with
base. This observation supports that the total Int-B is a sum of
Int-B generated by TSase and Int-B artificially generated from
covalent intermediate(s) in the presence of base. Surprisingly,
formation and decay of the covalent intermediate(s) were con-
siderably slower (ca. threefold) than formation and decay of total
noncovalent Int-B observed in the base quench. Therefore, we
concluded that covalent intermediates are largely represented
by the species forming parallel to the major pathway leading
to the product dTMP. In agreement with this interpretation,
previous studies by Hardy and coworkers (16, 17) suggested
that covalent ternary complex Int-A is especially vulnerable to
overstabilization by EcTSase, and it is likely a nonproductive
fully reversible complex that branches from the major reaction
pathway.
Fig. 2. Single-turnover kinetics of the EcTSase-catalyzed reaction measured
by rapid chemical quench with NaOH: time course for [2-14C]dUMP (pink)
consumption, dTMP (green) formation, and Int-B (blue) transient genera-
tion. Reaction conditions: 100 μM EcTSase (dimer), 80 μM [2-14C]dUMP,
200 μM CH2H4F, 100 mM Tris·HCl, pH 7.5, 50 mM MgCl2, 25 mM DTT, and
7 mM HCHO at 25 °C. Single-turnover kinetics of the EcTSase-catalyzed
reaction measure by rapid chemical quench with HCl: time course for
[3ʹ,5ʹ,7,9-3H]CH2H4F derived covalently bound to the enzyme intermediates
(red). Reaction conditions: 150 μM EcTSase (dimer), 400 μM dUMP, 80 μM
[3ʹ,5ʹ,7,9-3H]CH2H4F, 100 mM Tris·HCl, pH 7.5, 50 mM MgCl2, 25 mM DTT, and
7 mM HCHO at 25 °C. Dots represent experimental data points, and lines are
the global fit of the entire dataset (including additional steady-state and
presteady-state kinetics data provided in SI Appendix) to SI Appendix,
Scheme S1 (kinetic model based on the QM/MM proposed molecular
mechanism outlined in Fig. 3A) using KinTek Explorer. Each curve was
reproduced in at least two independent experiments.
Fig. 3. QM/MM proposed molecular mechanism of the bisubstrate intermediates interconversion in the active site of TSase (A) and the corresponding free-
energy profile (B).































Agreement Between QM/MM Calculations and Experimental Data
Supports Existence of Parallel Pathways and Prevalence of Noncova-
lent Intermediates in TSase Catalytic Mechanism. To get a deeper
insight into the mechanism complementing and supporting the
kinetic studies, hybrid QM/MM calculations have been carried
out with the QM subset of atoms described at the density func-
tional theory (DFT) level with the B3LYP (Becke, 3-parameter,
Lee-Yang-Parr) functional and the rest of the protein and
solvating water molecules treated with OPLS-AA (optimized
potential for liquid simulations–all atom) and TIP3P (transfer-
able intermolecular potential–3 point) classical force fields, re-
spectively (SI Appendix has details). The obtained free-energy
landscape of the reaction suggests that Int-B partitions between
its N5- and O4-protonated forms (Fig. 3). However, the H4F and
exocyclic methylene intermediate products can be reached only
from a direct C7-N5FOL cleavage from Int-B-N5H as previ-
ously proposed (6). In contrast, productive decomposition of Int-
BO4H must proceed either through reversal to Int-B followed by
N5 protonation or through the significantly higher-energy direct
formation of Int-B-N5H. Interestingly, calculations suggest that
an alternative fate of IntB-O4H involves restoration of the C6-S
bond, resulting in covalent species Int-AO4H. The latter is ef-
fectively a dead-end species, as no forward pathway toward
product formation was found. Notably, this prediction agrees
with the experimentally suggested conclusion that the covalent
bisubstrate intermediate is predominantly forming in a parallel
nonproductive reaction pathway.
Directed by the molecular mechanism outlined in Fig. 3A and
using KinTek Explorer, we globally fit the entire set of the rapid
quench data and previously obtained steady-state and presteady-
state kinetics of the reaction [including steady-state kinetics
of externally added Int-B turnover (15)] and found a solution
consistent with the proposed pathway (Fig. 2A, global fit; SI
Appendix has details). Since it was only possible to monitor a
total pool of bisubstrate intermediates and its subset corre-
sponding to covalent species, the kinetics of each individual in-
termediate was simulated and represents one of the possible
solutions, which globally fits to experimental data points. How-
ever, we were able to achieve a reasonably good agreement be-
tween QM/MM calculations and the global fit to experimental
data combined with the simulation. First, both QM/MM calcu-
lations and the KinTek simulation predict that the total pool
of bisubstrate intermediates is predominantly represented by
noncovalent species, where the Int-B-N5H form is likely the
most stable intermediate. Second, partitioning of Int-B between
two parallel pathways happens with comparable probabilities.
Third, formation of “dead-end” covalent intermediate Int-A-
O4H on restoration of C6-S bond to Int-B-O4H is a thermody-
namically favorable process that competes with the reversal of
Int-B-O4H to Int-B and therefore, the productive reaction path.
In summary, this work provides several important milestones
to the current knowledge of the catalytic mechanism of TSase.
Specifically, we report isolation and characterization of the intact
noncovalent bisubstrate intermediate of the reaction. Investiga-
tion of the interconversions of this intermediate through the
combination of QM/MM methods, experiments, and kinetic
modeling reveals that this noncovalent species is indeed the
major productive intermediate along the reaction pathway,
whereas the covalent species forms in a parallel nonproductive
pathway. Both computational and experimental results reinforce
each other in their description of a branched path mechanism,
where a covalent bisubstrate species is implicated as an over-
stabilized intermediate of the reaction. The latter finding could
be a useful direction for TSase-targeted drug discovery, as it
unveils a weak spot in the catalytic mechanism, which could be
exploited in efforts to inhibit the enzyme.
Materials and Methods
Detailed information on the EcTSase expression and purification, labeled
substrate synthesis, enzymatic assays, rapid chemical quench procedures,
HPLC analysis, data fitting and kinetic modeling with KinTek Explorer,
computational methods, and QM/MM free-energy surfaces is provided in
SI Appendix.
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